Marilena Vrana Urges EU Policymakers to “Keep Patients at the Centre” of Critical Medicines Act
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared on LinkedIn:
“Yesterday’s vote in the European Parliament marks an important shift in how Europe prepares for and protects access to critical medicines. The SANT Committee’s decision to refine the scope of the Critical Medicines Act (CMA), by recognising the distinct characteristics of different pharmaceutical supply chains, is a welcome move.
For the CMA to reach its full potential and properly safeguard patients, it needs to account for how medicines are actually developed and manufactured. Plasma-derived medicines, which rely on voluntary donations and complex production processes, demonstrate why tailored policy solutions and regulatory flexibility are essential.
As the trilogues will begin in the new year, I look forward to Council of the European Union and European Commission to align with the EP’s position on this matter.
I also urge policymakers to keep patients at the centre of their thinking during these negotiations. Access and availability of medicines must be prioritised. Unilateral and uncoordinated national stockpiling can have unwanted consequences on PDMP supply, which is why PPTA Europe recommends avoiding national stockpiling and limiting EU-level stockpiling to clearly defined crisis situations.
Read PPTA’s full statement in response to the recent vote.”
Read more about PPTA updates on Hemostasis Today.
-
Mar 18, 2026, 16:34Richard Buka: Exploring the COBRRA Trial in the Latest Episode of Don’t Just Read the Abstract
-
Mar 18, 2026, 16:22Heghine Khachatryan: Navigating the New Era of Hemophilia Gene Therapy
-
Mar 18, 2026, 16:21Georges Chahoud: Top Take-Home Messages from the AHA/ACC/Multisociety Acute PE Guideline
-
Mar 18, 2026, 16:19Cedric Hermans: Unleashing the Potential of Physical Activity in Hemophilia A Patients
-
Mar 18, 2026, 16:17Asif Mushtaq: Managing Cardiac Surgery with Cardiopulmonary Bypass in Hemophilia
-
Mar 18, 2026, 16:15Amir Kraitzer: Engineering Hemocompatible Surfaces to Overcome Thrombosis in Medical Devices
-
Mar 18, 2026, 16:11Hemant Sharma: Advancing Neonatal Care with New Strategies to Prevent IVH
-
Mar 18, 2026, 16:09Yves Bikorimana: How a Simple Temperature Change Can Trigger Antibody-Mediated Destruction of RBCs
-
Mar 18, 2026, 16:07Scott Isaacs: Optimizing Brain Vitality and Slowing Neurodegeneration Through Daily Habits